Adverse effects of long-term proton-pump inhibitor therapy on adults

被引:6
|
作者
Igaz Ivan [1 ]
Simonyi Gabor [2 ]
Balogh Sandor [3 ]
Szathmari Miklos [1 ]
机构
[1] Semmelweis Egyet, Altalanos Orvostud Kar, Belgyogyaszati Klin 1, Budapest, Hungary
[2] Szent Imre Egyet Oktatokorhaz, Anyagcsere Kozpont, Budapest, Hungary
[3] Pecsi Tud Egyet, Altalanos Orvostud Kar, Alapellatasi Int, Pecs, Hungary
关键词
proton pump inhibitor; Clostridium difficile; osteoporosis; dementia; pneumonia; CLOSTRIDIUM-DIFFICILE INFECTION; KIDNEY-DISEASE; RISK; METAANALYSIS; ASSOCIATION; DEMENTIA; FRACTURE;
D O I
10.1556/650.2018.31057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the last few decades, proton-pump inhibitors have become the mainstay of the treatment of acid-related disorders. Despite their efficacy, these drugs are not without risks. Recently several articles have been published on their long-term adverse effects. Among these adverse effects, the higher risk of bone fractures, the vitamin B-12 and magnesium deficiencies and the higher risk of Clostridium difficile infection may be relevant. As these drugs are prescribed more and more frequently all over the world, the knowledge of the long-term adverse effects is very important not only for the specialists but for the general practitioners as well. In this review, the authors discuss the recent findings in this field, emphasising that the long-term use of these drugs must be based on an adequate and strong indication.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 50 条
  • [1] Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
    Sheen, Edward
    Triadafilopoulos, George
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (04) : 931 - 950
  • [2] Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
    Edward Sheen
    George Triadafilopoulos
    [J]. Digestive Diseases and Sciences, 2011, 56 : 931 - 950
  • [3] Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence
    Maes, Marina L.
    Fixen, Danielle R.
    Linnebur, Sunny Anne
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (09) : 273 - 297
  • [4] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Holmberg, Dag
    Lagergren, Jesper
    [J]. JOURNAL OF GASTROENTEROLOGY, 2023, 58 (02) : 183 - 183
  • [6] Pharmacist-Driven Step-Down of Long-Term Proton-Pump Inhibitor Therapy
    Quinn, Rachel
    Park, Karen M.
    Bodine, Rita
    [J]. SENIOR CARE PHARMACIST, 2019, 34 (08): : 520 - 528
  • [7] Adverse Effects of Long-Term Proton Pump Inhibitor Use: A Review for the Otolaryngologist
    Chapman, D. Brandon
    Rees, Catherine J.
    Lippert, Dylan
    Sataloff, Robert T.
    Wright, S. Carter, Jr.
    [J]. JOURNAL OF VOICE, 2011, 25 (02) : 236 - 240
  • [8] Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy
    Helge Waldum
    [J]. Journal of Gastroenterology, 2023, 58 : 182 - 182
  • [9] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Dag Holmberg
    Jesper Lagergren
    [J]. Journal of Gastroenterology, 2023, 58 : 183 - 183
  • [10] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Dag Holmberg
    Fredrik Mattsson
    Shaohua Xie
    Eivind Ness-Jensen
    Hashem El-Serag
    Jesper Lagergren
    [J]. Journal of Gastroenterology, 2022, 57 : 942 - 951